Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2012

Novatel Wireless, Inc. (NVTL) Receives 2012 Mobile Merit Awards in ‘Gadgets, Handsets, and Devices’ and ‘Mobile Health’ Categories

Leading intelligent wireless solutions provider Novatel Wireless announced today its 4G LTE MiFi 4620L Intelligent Mobile Hotspot has been selected as a winner in the gadgets, handsets, and devices category for the 2012 Mobile Merit Awards for the third year … Continue reading

Posted in Small Cap News | Leave a comment

Zalicus, Inc. (ZLCS) Finalizes Patient Enrollment in Phase IIb Trial of Synavive

Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The company has a number of proprietary drug product candidates that are currently in clinical trials. The company today announced it … Continue reading

Posted in Small Cap News | Leave a comment

SEFE, Inc. (SEFE) Provides Overview of Tether Contact System

Today, SEFE, a technology- and solutions-driven sustainability company, introduced a summary of its tether contact system and its role in the company’s flagship Harmony III product. The tether contact system is designed to minimize electrical path length on the power … Continue reading

Posted in SEFE Inc. SEFE | Leave a comment

NDB Energy, Inc. (NDBE) Acquires Armada Oil, 25k Acres of Prime Niobrara Shale/Casper Sandstone Targets

NDB Energy, the aggressive, emerging oil and gas company, running the gamut operationally from exploration to production and marketing, via an ever-growing portfolio of carefully chosen undervalued, underdeveloped, and underperforming targets, recently reported yet another judicious growth initiative, securing key … Continue reading

Posted in Small Cap News | Leave a comment

Autobytel, Inc. (ABTL) Profitably Matches Consumers to Car Dealers Online

Autobytel helps consumers find cars and obtain financing, and provides other services over the Internet. Located in California, Autobytel has been in business since 1995 and pioneered online auto marketing. Autobytel is well positioned to benefit as, more and more, … Continue reading

Posted in Small Cap News | Leave a comment

NDB Energy, Inc. (NDBE) is “One to Watch”

NDB Energy is an emerging independent oil and gas company that explores for, develops, produces, and markets crude oil and natural gas from various known prolific and productive geological formations. The company is focused on building and developing a portfolio … Continue reading

Posted in Ones to Watch | Leave a comment

VistaGen Therapeutics (VSTA) Develops Superior Drug Testing Technology

Human pluripotent stem cells are the foundation for VistaGen’s development of advanced stem cell technologies to create superior drug testing opportunities for pharmaceutical companies. Pluripotent stem cells are able to self-renew as well as differentiate into specialized cells like heart … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Kodiak Oil & Gas Corp. (KOG) Updates Investors on Q1 2012 Activity

Kodiak Oil and Gas released a financial and operational update for the first quarter of 2012. The company is actively developing the Bakken play in the Williston Basin of North Dakota. Kodiak Oil reported oil and gas production of 10,578 … Continue reading

Posted in Small Cap News | Leave a comment

Simulations Plus, Inc. (SLP) Releases Version 8.0 of Its Best-in-Class GastroPlus Simulation Software

Simulations Plus today announced it has released Version 8.0 of GastroPlus, its flagship simulation software. GastroPlus 8.0 features significantly enhanced functionality and user convenience, representing a substantial upgrade of the company’s industry-leading drug absorption, pharmacokinetics, and pharmacodynamics simulation software. Among … Continue reading

Posted in Small Cap News | Leave a comment

Ampio Pharmaceuticals, Inc. (AMPE) Secures Key US/Canadian Patents for Diabetes-Related Vision Loss Drug Optina™

Today, Ampio Pharmaceuticals, the dynamic biopharma developer which has assembled an impressive portfolio of proprietary drugs for treating eye (diabetic macular edema – Optina™), kidney, and metabolic disease, as well as chronic inflammation (Ampion™), male sexual dysfunction (Zertane™), and central … Continue reading

Posted in Small Cap News | Leave a comment